{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:07:37Z","timestamp":1789744057212,"version":"4.0.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14033-8","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:44:21Z","timestamp":1788486261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparable tolerability, symptom worsening, and treatment completion rates among different Helicobacter pylori eradication regimens in children"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1813-7780","authenticated-orcid":false,"given":"Neslihan","family":"G\u00fcrcan Kaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0563-4112","authenticated-orcid":false,"given":"Suna","family":"Selbuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"issue":"3","key":"14033_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1128\/CMR.00054-05","volume":"19","author":"JG Kusters","year":"2006","unstructured":"Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19(3):449\u201390.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"14033_CR2","first-page":"e32","volume":"6","author":"JP Gisbert","year":"2013","unstructured":"Gisbert JP, Calvet X. Helicobacter pylori test-and-treat strategy for management of dyspepsia: a comprehensive review. Therapeutic Adv Gastroenterol. 2013;6(3):e32.","journal-title":"Therapeutic Adv Gastroenterol"},{"issue":"3","key":"14033_CR3","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/jpn3.12314","volume":"79","author":"M Homan","year":"2024","unstructured":"Homan M, Jones NL, Bontems P, Carroll MW, Czinn SJ, Gold BD, et al. Updated joint ESPGHAN\/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents. J Pediatr Gastroenterol Nutr. 2024;79(3):758\u201385. https:\/\/doi.org\/10.1002\/jpn3.12314.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"14033_CR4","first-page":"757","volume":"11","author":"HH Lai","year":"2022","unstructured":"Lai HH. Treatment of pediatric Helicobacter pylori infection. J Clin Med. 2022;11(6):757.","journal-title":"J Clin Med"},{"key":"14033_CR5","doi-asserted-by":"publisher","first-page":"175628482311700","DOI":"10.1177\/17562848231170052","volume":"16","author":"M Manfredi","year":"2023","unstructured":"Manfredi M, Gargano G, Gismondi P, Ferrari B, Iuliano S. Therapeutic eradication choices in Helicobacter pylori infection in children. Therapeutic Adv Gastroenterol. 2023;16:17562848231170052.","journal-title":"Therapeutic Adv Gastroenterol"},{"issue":"2","key":"14033_CR6","doi-asserted-by":"publisher","first-page":"e12776","DOI":"10.1111\/hel.12776","volume":"26","author":"T Kakiuchi","year":"2021","unstructured":"Kakiuchi T, Matsuo M, Endo H, et al. Gastrointestinal adverse reactions reduce the success rate of Helicobacter pylori eradication therapy: a multicenter prospective cohort study. Helicobacter. 2021;26(2):e12776.","journal-title":"Helicobacter"},{"issue":"5","key":"14033_CR7","first-page":"e","volume":"13","author":"M Hafeez","year":"2021","unstructured":"Hafeez M, Qureshi ZA, Khattak AL, et al. Helicobacter pylori eradication therapy: still a challenge. Cureus. 2021;13(5):e.","journal-title":"Cureus"},{"issue":"8","key":"14033_CR8","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","volume":"102","author":"WD Chey","year":"2007","unstructured":"Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102(8):1808\u201325.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"14033_CR9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/00365529709011203","volume":"32","author":"SJ Lewis","year":"1997","unstructured":"Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920\u20134.","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"14033_CR10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1097\/MPG.0000000000001594","volume":"64","author":"NL Jones","year":"2017","unstructured":"Jones NL, Koletzko S, Goodman K, et al. Joint ESPGHAN\/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents. J Pediatr Gastroenterol Nutr. 2017;64(6):991\u20131003.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"14033_CR11","first-page":"1220","volume":"53","author":"OP Nyssen","year":"2021","unstructured":"Nyssen OP, Perez-Aisa A, Tepes B, et al. Adverse event profile during the treatment of Helicobacter pylori: a real-world experience of 22,000 patients from the European registry (Hp-EuReg). Aliment Pharmacol Ther. 2021;53(6):1220\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"14033_CR12","first-page":"229","volume":"32","author":"SB Kwon","year":"2010","unstructured":"Kwon SB, Lee KL, Kim JS, et al. Antibiotics-associated diarrhea and other gastrointestinal adverse reactions during Helicobacter pylori eradication. Aliment Pharmacol Ther. 2010;32(2):229\u201335.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"14033_CR13","first-page":"89","volume":"52","author":"AG McNicholl","year":"2020","unstructured":"McNicholl AG, Bordin DS, Lucendo A, et al. Combination of bismuth and standard triple therapy eradicates Helicobacter pylori infection in more than 90% of patients. Aliment Pharmacol Ther. 2020;52(1):89\u201398.","journal-title":"Aliment Pharmacol Ther"},{"issue":"48","key":"14033_CR14","doi-asserted-by":"publisher","first-page":"7361","DOI":"10.3748\/wjg.14.7361","volume":"14","author":"AC Ford","year":"2008","unstructured":"Ford AC, Malfertheiner P, Gigu\u00e8re M, et al. Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis. World J Gastroenterol. 2008;14(48):7361\u20138.","journal-title":"World J Gastroenterol"},{"key":"14033_CR15","first-page":"1663","volume":"53","author":"P Hillemand","year":"1977","unstructured":"Hillemand P, Palliere M, Laquais B, Bouvet P. Bismuth treatment and blood bismuth levels. La Semaine des H\u00f4pitaux. 1977;53:1663\u20139.","journal-title":"La Semaine des H\u00f4pitaux"},{"issue":"1","key":"14033_CR16","first-page":"397","volume":"23","author":"AH Ceruelos","year":"2019","unstructured":"Ceruelos AH, Romero-Quezada LC, Ledezma JR, Contreras L. Therapeutic uses of metronidazole and its side effects: an update. Eur Rev Med Pharmacol Sci. 2019;23(1):397\u2013401.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"14033_CR17","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/gut.2009.192757","volume":"59","author":"DY Graham","year":"2010","unstructured":"Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010;59(8):1143\u201353.","journal-title":"Gut"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14033-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14033-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14033-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:30:22Z","timestamp":1789741822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-14033-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14033"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14033-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1680"}}